Skip to content
OpenCapital
Get started

Axon Enterprise, Inc. AXON Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
Other countries20%+66.7%

Other financials

Income statement

See full
Revenue$807.3M+33.7%
Gross profit$477.3M+30.5%
Operating income$29.2M+433%
Net income$169.3M+92.4%
EPS (diluted)$2.05+89.8%

Balance sheet

See full
Cash & equivalents$458.9M-58.0%
Total debt$1.8B-10.7%
Total equity$3.5B+38.3%
Total assets$7.1B+16.2%

Cash flow

See full
Operating cash flow-$31.5M-222%
CapEx$23.1M-7.0%
Free cash flow-$54.6M-5,963%

Valuation

See full
Market cap$37.47B-39.4%
Enterprise value$38.84B-38.6%
P/E181.9×-7.6×
P/S12.6×-13.3×

Profitability

See full
Gross margin59.3%-1.3pp
Operating margin-0.8%—
Net margin6.9%-8.0pp
FCF margin0.7%-15.6pp

Returns & leverage

See full
Return on equity6.8%-8.4pp
Debt / equity0.5×-0.3×
Current ratio2.3×-0.6×